2-Dimethylaminopyridine → HCID 59295414, compound
Reaction equation
[Cl:1][C:2]1[CH:9]=[C:8]([O:10][CH2:11][C:12]2[S:16][C:15]([CH:17]3[CH2:22][CH2:21][NH:20][CH2:19][CH2:18]3)=[N:14][C:13]=2[CH3:23])[CH:7]=[CH:6][C:3]=1[C:4]#[N:5].C(N(CC)C(C)C)(C)C.CN(C1C=CC=CN=1)C.[F:42][C:43]([F:49])([F:48])[S:44](Cl)(=[O:46])=[O:45]>ClCCl>[Cl:1][C:2]1[CH:9]=[C:8]([O:10][CH2:11][C:12]2[S:16][C:15]([CH:17]3[CH2:22][CH2:21][N:20]([S:44]([C:43]([F:49])([F:48])[F:42])(=[O:46])=[O:45])[CH2:19][CH2:18]3)=[N:14][C:13]=2[CH3:23])[CH:7]=[CH:6][C:3]=1[C:4]#[N:5]Participants
6
Procedure
500 mg 2-Chloro-4-(4-methyl-2-piperidin-4-yl-thiazol-5-ylmethoxy)-benzonitrile was dissolved in 20 ml dichloromethane. 0.25 ml N,N-Diisopropylethylamine and 50 mg dimethylaminopyridine were added. Then 0.26 ml trifluoromethanesulfonylchloride were added to the ice cooled reaction mixture. The cooling bath was removed and the reaction mixture stirred at room temperature overnight. The reaction mixture was washed with 10 ml saturated NaHCO3 solution and then dried over MgSO4. The solvent was removed in Vacuo. The resulting crude material was purified by reversed phase HPLC to obtain 350 mg 2-Chloro-4-[4-methyl-2-(1-trifluoromethanesulfonyl-piperidin-4-yl)-thiazol-5-ylmethoxy]-benzonitrile as amorphous solid.
Workup
- temperaturecooled
- customreaction mixture
- customThe cooling bath was removed
- washThe reaction mixture was washed with 10 ml saturated NaHCO3 solution
- dry with materialdried over MgSO4
- customThe solvent was removed in Vacuo
- customThe resulting crude material was purified by reversed phase HPLC
Sources & evidence
- ORD record
- ord-53ee299b1a134e8585a7c1f4619f998e
- Source dataset
- uspto-grants-2010_05
- Patent number
- US07709481B2
Reaction notes
Loading…